Navigation Links
Dengue fever costs billions in health care, lost productivity and absenteeism
Date:5/7/2009

Waltham, MAResearchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries. The study, published in the May issue of the American Journal of Tropical Hygiene, assessed the direct and indirect costs of dengue cases in eight American and Asian countries, tallying the collective economic burden of dengue in those countries at about $1.8 billion annually.

About 2.5 billion people, two-fifths of the world's population, live in parts of the world affected by dengue, and an additional 120 million people travel to dengue-affected areas annually. Between 50 and 100 million people are infected each year, and the World Health Organization says the number is rising due to human population growth and the increased spread of vector mosquitoes. Unlike malaria, dengue is more prevalent in urban than rural areas. Dengue illness involves sudden severe headache, muscle and joint pain, diarrhea, vomiting, and a high fever typically lasting about a week. In a small number of cases, it develops into dengue hemorrhagic fever and proves fatal.

The study set out to estimate the true economic costs of a case of dengue, whether the patient was treated at home or in the hospital, including school absenteeism, lost productivity, and the unpaid time of caregivers.

"This study shows that a case of dengue affects not only the patient, but also other household members who must take off from work of school to provide care," said coauthor Donald Shepard, Ph.D, a health economist at the Heller School for Social Policy and Management at Brandeis University.

Five countries in the Americas participated in the study: Brazil, El Salvador, Guatemala, Panama, and Venezuela, along with three Asian nations: Cambodia, Malaysia, and Thailand.

"We found that that the economic cost of this disease is highat least $1.8 billion yearly in these 8 countries after adjusting for price differences and under-reporting of cases," said lead author Jose Suaya, M.D., Ph.D., a visiting scholar at Brandeis's Heller School.

Because mosquitoes transmit the disease, patients come from all age groups and economic levels. While 29% of patients came from households with less than primary education, 27% were from households with some college or equivalent. The study followed 1,695 patients. The average illness lasted about 11 days, whether the patient was hospitalized or treated in clinics, although hospitalized cases averaged about three times the cost of ambulatory patients.

"Our study shows that dengue poses a very heavy economic burden to the health system and society, and it underscores the need for full development of preventive measures, such as a dengue vaccine and vector control," said Suaya.


'/>"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
Source:Eurekalert

Related medicine news :

1. Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment
2. New test may help to ensure that dengue vaccines do no harm
3. Mosquito mating mechanism could lead to new attack on dengue and yellow fever
4. Biologists Discover How Dengue Virus Matures
5. Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine
6. Substantial costs and underreporting of dengue fever, concerns about blood supply face US
7. Support at Fever Pitch for Dynamic, Fresh Approach to Pharmaceutical Competitive Intelligence
8. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
9. RNC: Tax and Spend Fever
10. Biomarkers detected for Chikungunya fever
11. Hay fever may be best treated with self-adjusted dosing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... prominently feature 150+ Hospital and Health System Executive Speakers including: , , ... President of the United States of America: George W. Bush , Boxing Legend, ... Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... help improve all aspects of people’s health and nutrition, announced its product Leyzene ... , Natural Subsistence develops nutritional supplements that help people improve all aspects ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 — ... the new EU MDR language change the way manufacturers approach CERs? , ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Beyond and Back”: a true-life ... is the creation of published author Bonetta Rose, a wife, mother and grandmother committed ... Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual events in the ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... ReNeuron reported in December 2016 positive Phase II trial ... not meeting the three-month time frame of a two-point improvement ... (ARAT). As a result, the company has confirmed that it ... Beyond CTX, we expect safety and efficacy data from its ... from its critical limb ischaemia (CLI) trial. Our rNPV has ...
(Date:3/23/2017)... , Mar 23, 2017 The Board ... to the Annual General Meeting, which is to take place on ... 2 in Lund, Sweden . ... Please see the attached notification, which ... Inrikes Tidningar. NeuroVive Pharmaceutical AB (Publ) The Board Of ...
(Date:3/22/2017)... Corp. (NASDAQ: DRIO), a leading global digital health ... today reported financial and operational results for the ... 2016. 2016 Highlights ... to the full year 2015  ... Direct-to-consumer model launched in U.S. ...
Breaking Medicine Technology: